-
Pharma Reta 30 (Retatrutide 30mg) – Next-Generation Triple-Agonist Peptide for Extreme Metabolic Optimization
-
Explain what it is. Retatrutide (LY3437943). 30mg per vial. It’s a triple hormone receptor agonist (GLP-1, GIP, and Glucagon). Step up from Tirzepatide (which is dual) and Semaglutide (which is single).
-
Mechanism (The Triple Agonist):
-
GLP-1 (Glucagon-like peptide-1): Appetite suppression, delayed gastric emptying.
-
GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin secretion, fat storage regulation.
-
GCGR (Glucagon receptor): Increases basal metabolic rate, burns stored fat directly via liver lipid metabolism.
-
Sale!
RETA 30
Original price was: $80.00.$72.00Current price is: $72.00.
-
Key Benefits: Massive fat loss (clinical trials show up to 24%+ body weight loss), extreme appetite control, enhanced energy expenditure, breaking through weight loss plateaus.
-
Technical Specifications:
-
Product Name: Reta 30 (Retatrutide)
-
Active Ingredient: Retatrutide (LY3437943)
-
Format: 30mg Lyophilized Powder
-
Classification: Triple Incretin Agonist (GLP-1/GIP/GCGR)
-
Primary Goal: Extreme fat loss, metabolic research, appetite suppression
-




Reviews
There are no reviews yet.